Shanghai Haohai Biological Technology Co Ltd Shs -H- Unitary 144A/Reg S 06826
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HK$15.56
- Day Range
- HK$15.45–15.64
- 52-Week Range
- HK$15.04–28.18
- Bid/Ask
- HK$15.52 / HK$15.59
- Shares Outstanding
- 223.92M
- Market Cap
- HK$3.48B
- Volume/Avg
- 81,800 / 93,923
Key Statistics
- Price/Earnings (Normalized)
- 20.51
- Price/Sales
- 1.38
- Dividend Yield (Trailing)
- 6.30%
- Dividend Yield (Forward)
- 6.30%
- Dividend Payment Schedule
- Jul, Oct
- Total Yield
- 7.72%
Company Profile
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to a single operating segment, which is the manufacture and sale of biologicals, medical hyaluronate, and intraocular lenses, research and development of biological engineering and pharmaceutical products, and the provision of related services. Its products are categorized into four types, comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China, which is the key revenue driver, the United States, the United Kingdom, and other countries.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,999
- Website
- https://www.3healthcare.com
Valuation
Metric | 06826 |
|---|---|
Price/Earnings (Normalized) | 20.51 |
Price/Book Value | 0.56 |
Price/Sales | 1.38 |
Price/Cash Flow | 10.70 |
Price/Earnings
06826
Financial Strength
Metric | 06826 |
|---|---|
Quick Ratio | 2.95 |
Current Ratio | 3.49 |
Interest Coverage | 6.50 |
Quick Ratio
06826
Profitability
Metric | 06826 |
|---|---|
Return on Assets (Normalized) | 4.16% |
Return on Equity (Normalized) | 5.21% |
Return on Invested Capital (Normalized) | 4.40% |
Return on Assets
06826
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|cX%!?WV | LOCK|#<%L | $137B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|p%!G%F | LOCK|@$hmc | $99B | |||
| Moderna Inc MRNA | LOCK|#FJf<# | LOCK|rB> | $90B | |||
| argenx SE ADR ARGX | LOCK|NRZX<^Y | LOCK|^r | $61B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|$nq#Tc | LOCK|f^< | $48B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|sTmVqwp! | LOCK|XX!P# | $31B | |||
| Incyte Corp INCY | LOCK|&#k!zz | LOCK|&Y | $25B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|>GS@qrj | LOCK|Q!H$ | $22B | |||
| BioNTech SE ADR BNTX | LOCK|M>D<n! | LOCK|<F^ | $21B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|PGGPQw | LOCK|c! | $16B |
United States